• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WAN Li, SUN Jinnan, DING Zuoqi, HAO Haiping. Research on the development of bio-pharmaceutical industry integration and collaborative innovation in the Yangtze River Delta under the mode of Industry-University-Research cooperation[J]. Journal of China Pharmaceutical University, 2022, 53(6): 742-752. DOI: 10.11665/j.issn.1000-5048.20220614
Citation: WAN Li, SUN Jinnan, DING Zuoqi, HAO Haiping. Research on the development of bio-pharmaceutical industry integration and collaborative innovation in the Yangtze River Delta under the mode of Industry-University-Research cooperation[J]. Journal of China Pharmaceutical University, 2022, 53(6): 742-752. DOI: 10.11665/j.issn.1000-5048.20220614
shu

Research on the development of bio-pharmaceutical industry integration and collaborative innovation in the Yangtze River Delta under the mode of Industry-University-Research cooperation

  • 1.

    School of International Pharmaceutical Business, China Pharmaceutical University,Nanjing 211198

  • 2.

    Editorial Board of Chinese Journal of Natural Medicines, China Pharmaceutical University, Nanjing 210009

  • 3.

    School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China

Funds: This study was supported by the Subject of Jiangsu Provincial Science Association Research in 2022 （No.JSKXKT 2022018） and the Development Strategy of China Pharmaceutical University during the Fourteenth Five-Year Plan and the Subject of Comprehensively Deepening Reform Research in 2022
More Information
  • Received Date: October 27, 2022
  • Revised Date: November 27, 2022
    Graphical Abstract
    • Abstract
  • After the integration of Yangtze River Delta was elevated and developed into a national strategy, few domestic studies have been conducted to explore the integrated and collaborative development of biopharmaceutical industry in the Yangtze River Delta region, which, as an important region of biopharmaceutical industry in China, has initially formed the development mode of industrial clusters. In this study, based on the industry-university-research model of patent and fund project cooperation, the social network analysis (SNA) method is used to analyze and study the cooperation of patent and Major Projects of National Natural Science Foundation of China in the biopharmaceutical industry in the Yangtze River Delta region. The study shows that the industry-university-research cooperation in the biomedical field in the Yangtze River Delta region is still in the development stage and the degree of integration needs to be improved. Universities and research institutes are more inclined to cooperate with enterprises for invention patents and with other universities for fund project research.It is suggested that the Yangtze River Delta region should adopt the deep integration mode of industry-university-research, relevant leading scientific research institutions should establish open innovation platforms, and pharmaceutical universities should cultivate innovative talents with the advantages of their disciplines, and adopt "Revealing the List and Taking Command" or other ways to tackle key core technologies.
    • FullText(HTML)
    • References (21)
  • [1]
    . People's Daily（人民日报），2021-03-13（001）.
    [2]
    National Development and Reform Commission. The 14th Five-Year Plan for the development of bioeconomy［A/OL］. （2021-12-20）［2022-10-07］. https：//www.ndrc.gov.cn/xwdt/tzgg/202205/P020220510324283427632.pdf.
    [3]
    Liu ZB，Chen L. Demonstration value and motivation mechanism of regional integration development in the Yangtze River Delta Region［J］. Reform（改革），2018（12）：65-71.
    [4]
    The State Council of the People's Republic of China. Outline of the Yangtze River Delta Regional Integrated Development Plan ［EB/OL］. （2019-12-01）［2022-10-07］．http：//www.gov.cn/zhengce/2019/12/01/content_5457442.html.
    [5]
    Ministry of Science and Technology of the People′s Republic of China. Notice of the Ministry of Science and Technology on the issuance of the yangtze river delta science and technology innovation community construction and development plan［EB/OL］. （2020-12-20）［2022-10-07］. https：//www.most.gov.cn/xxgk/xinxifenlei/fdzdgknr/fgzc/gfxwj/gfxwj2020/202101/t20210113_172235.html.
    [6]
    Tang CL，Gu X. Research on the source and formation of knowledge advantage of Industry-University-Research Cooperation Innovation Network［J］. Scie Technol Manag Res （科技管理研究），2010，30（11）：113-116.
    [7]
    Suzhou Industrial Park Management Committee. Yangtze River Delta Biomedical Industry Chain Alliance established in Suzhou Industrial Park［EB/OL］. （2021-05-25）［2022-10-07］. http：//www.suzhou.gov.cn/szsrmzf/qxkx/202105/43f7b410a0a0488d95d37e474675b18d.shtml.
    [8]
    Shanghai Municipal Commission of Economy and Information Technology. Implementation plan on promoting the development of biomedical industrial park features［A/OL］. （2020-10-22）［2022-10-07］. http：//sheitc.sh.gov.cn/cmsres/c1/c1ca71efc 0994c7e8c0d64bc1e8070f1/ed2a2092d1d182d37d33e168f2ac5e1f.pdf.
    [9]
    General Office of Zhejiang Provincial People's Government on the issuance of action plans to promote the high-quality development of biomedical industry （2022-2024）［J］. Gazette of the People's Government of Zhejiang Province（浙江省人民政府公报），2022（17）：20-25.
    [10]
    Xu P. The Research on the Development Status and Countermeasures of Anhui's Biomedical Industry［J］. Value Eng（价值工程），2014，33（4）：151-152.
    [11]
    Ministry of Science and Technology of the People's Republic of China. 2021 China Biomedical Industrial Park Competitive Evaluation and Analysis Report［EB/OL］. （2021-11-04）［2022-10-07］. https：//www.most.gov.cn/kjbgz/202111/t20211104_177831.html.
    [12]
    Shanghai Technology Exchange. Report on The Development of Regional Innovation Institutions in the Yangtze River Delta［EB/OL］. （2022-09-28）［2022-10-07］. http：//www.stte.com/articles/776.
    [13]
    The Organization Department of the Central Committee of the CPC. Notice on the issuance of the opinions on strengthening and Improving the party construction work of research institutes［EB/OL］. （2000-06-30）［2022-10-07］. http：//www.irsa.cas.cn/dj/gzzd/201011/t20101124_3029158.html.
    [14]
    Chen YW，Fang S. Application of Social Network Analysis （SNA） on patents networks analysis［J］. Library and Information Service（图书情报工作），2012，56（4）：90-95.
    [15]
    Wan YY，Wang QY，Zeng G，et al. Influencing mechanism of formation of innovation network between universities and biomedical firms：a case study of Yangtze River Delta［J］. Eco Geography（经济地理），2022，42（07）：146-158.
    [16]
    Liu R，Wang P，Yu J，et al. Obstacles and Countermeasures of Hospital Patent Transformation in China under the Background of Translational Medicine［J］. Hosp Adm J Chin PLA（解放军医院管理杂志），2017，24（2）：141-144.
    [17]
    Zhang ML. Current Situation and Risk Prevention of Collaborative Innovation between Universities，Enterprises and Research Institutes［J］. China Univ Sci Technol（中国高校科技），2017（10）：29-31.
    [18]
    Yu XX，Fan TH，Xu LJ，et al. Exploring the development of biomedical industrial park model of domestic and foreign universities based on Industry-University-Research cooperation［J］. Sci Technol Ind China（中国科技产业），2022（01）：60-63.
    [19]
    TORREYA. The Pharma 1000 Top Global Pharmaceutical Company Report［A/OL］.（2021-11-18）［2022-10-07］. https：//torreya. com/publications/pharma-1000-report-update-torreya-2021-11-18.pdf.
    [20]
    Wan L，Sun JN，Ding ZQ，et al. Research on the implementation strategy of “Revealing the List and Domination” system in the field of medicine based on policy text analysis［J］. Pharm Edu（药学教育），2022，38（4）：1-7.
    [21]
    Xie WQ，Tu J，Li GQ，et al. Research on the collaborative training mechanism of diversified biomedical talents in the context of “Healthy China”［J］.J Higher Edu（高教学刊），2022，8（15）：173-176，180.
    • Related Articles

  • Cited by

    Periodical cited type(9)

    1. 袁源，郭进利，郭曌华. 中国新能源汽车产业合作创新网络的空间格局及驱动机制. 科技创新发展战略研究. 2024(03): 3-16 .
    2. 岳新燕，阮娴静，徐恩怡，沈曼娜. 中山市生物医药产业竞争力评价及障碍因素分析. 科技和产业. 2024(12): 156-161 .
    3. 党子悦，项彦琳，谈维，郭冬梅. 基于产业集群视角的我国生物医药产业技术创新效率分析. 中国医药工业杂志. 2024(06): 879-886 .
    4. 张珵，李雨晴，李沿峰，邱欢，游欣语，蔡俊杰，李咏贤，李国兴，陈光阳，李承洪，冷梦妤，党元野. 基于专利文献分析广东省生物医药发展态势. 中国药业. 2024(21): 1-6 .
    5. 林巧，辛竹琳，周洪，邬金鸣，张学福. 生物领域重大科技计划决策机制与组织模式剖析. 科技管理研究. 2024(19): 193-200 .
    6. 龙晖，齐铮，吴昊. 重庆市生物医药产业发展现状与对策建议——以人才链为牵引加快生物医药高新园区社区建设. 中国生物工程杂志. 2023(05): 94-105 .
    7. 姜达洋，张匆匆. 推进产业政策创新 促进天津生物医药产业高质量发展. 产业创新研究. 2023(11): 1-5 .
    8. 姚胜菊. 中国式现代化建设背景下推进河北省生物医药产业高质量发展的路径选择. 经济论坛. 2023(07): 32-39 .
    9. 陈日生 ，徐伟 ，缪海华. 税收服务生物医药创新企业发展分析——基于苏州工业园区生物医药创新企业的调查研究. 国际税收. 2023(09): 53-57 .

    Other cited types(6)

Catalog

    Get Citation
    PDF
    XML
    Article views (200) PDF downloads (368) Cited by(15)
    Turn off MathJax
    Article Contents
    Abstract
    References

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：297149

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return